Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse

per Panicker, Sandip, Brown, Keith, Nicoll, Roger A.
Publicat 2008

Classical Complement Pathway Activation in ITP: Inhibition by a novel C1s inhibitor

per Peerschke, Ellinor I. B., Panicker, Sandip, Bussel, James
Publicat a Br J Haematol (2015)

Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel

per Panicker, Sandip, Cruz, Hans, Arrabit, Christine, Slesinger, Paul A.
Publicat a J Neurosci (2002)

Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity

per Colonna, Lucrezia, Parry, Graham C., Panicker, Sandip, Elkon, Keith B.
Publicat a Clin Immunol (2016)

C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro

per Nikitin, Pavel A., Rose, Eileen L., Byun, Tony S., Parry, Graham C., Panicker, Sandip
Publicat a J Immunol (2019)

Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003

per Valenzuela, Nicole M., Thomas, Kimberly A., Mulder, Arend, Parry, Graham C., Panicker, Sandip, Reed, Elaine F.
Publicat a Transplantation (2017)

Real-Time Imaging of Discrete Exocytic Events Mediating Surface Delivery of AMPA Receptors

per Yudowski, Guillermo A., Puthenveedu, Manojkumar A., Leonoudakis, Dmitri, Panicker, Sandip, Thorn, Kurt S., Beattie, Eric C., von Zastrow, Mark
Publicat 2007

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

per Bartko, Johann, Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Beliveau, Martin, Chang, Colin, Marier, Jean‐Francois, Nix, Darrell, Gilbert, James C., Panicker, Sandip, Jilma, Bernd
Publicat a Clin Pharmacol Ther (2018)

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human...

per Mühlbacher, Jakob, Jilma, Bernd, Wahrmann, Markus, Bartko, Johann, Eskandary, Farsad, Schörgenhofer, Christian, Schwameis, Michael, Parry, Graham C., Gilbert, James C., Panicker, Sandip, Böhmig, Georg A.
Publicat a Transplantation (2017)

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

per Gever, Joel R, Soto, Rothschild, Henningsen, Robert A, Martin, Renee S, Hackos, David H, Panicker, Sandip, Rubas, Werner, Oglesby, Ian B, Dillon, Michael P, Milla, Marcos E, Burnstock, Geoffrey, Ford, Anthony PDW
Publicat 2010

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

per Jäger, Ulrich, D’Sa, Shirley, Schörgenhofer, Christian, Bartko, Johann, Derhaschnig, Ulla, Sillaber, Christian, Jilma-Stohlawetz, Petra, Fillitz, Michael, Schenk, Thomas, Patou, Gary, Panicker, Sandip, Parry, Graham C., Gilbert, James C., Jilma, Bernd
Publicat a Blood (2019)